Exchange-Traded Funds, Equity Futures Higher Pre-Bell Tuesday Ahead of Economic Data Release
Eli Lilly Obesity Drug Shortage Ends Fueling Lawsuit Against FDA
Abbott Laboratories Analyst Ratings
Merck Posts Late-stage Trial Win for Keytruda in Head and Neck Cancer
Robots in the usa factory are starting to "lose their jobs"...
①In the USA factory, the work left for new siasun robot&automation seems to be decreasing... ②Many business executives express that as production lines and workshop businesses slow down, manufacturers are reducing the purchase of automation equipment; ③At the same time, in the USA labor market, more human workers are queuing up to find jobs.
J&J Discontinues Phase 2 Study for Bladder Cancer Drug TAR-200
How Is The Market Feeling About Abbott Laboratories?
Morgan Stanley's List of Tax Loss Selling Stocks
In-Depth Examination Of 11 Analyst Recommendations For AbbVie
Merck & Co Analyst Ratings
Amgen Analyst Ratings
AbbVie Analyst Ratings
10 Health Care Stocks Whale Activity In Today's Session
$1000 Invested In This Stock 5 Years Ago Would Be Worth $2,100 Today
(TMO) - Analyzing Thermo Fisher Scientific's Short Interest
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Monday Ahead of Q3 Earnings Season
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
Economist Justin Wolfers Points To Obesity Rate Decline As Ozempic And Wegovy Spur Historic Shift In Fight Against Obesity — Has US Reached A Turning Point?
Regeneron Co-founder Warns of Harms From Weight-loss Drugs: FT
Can Novo, Lilly Take Credit for U.S. Obesity Rate Decline?